Mitchell Sokoloff to Risk Assessment
This is a "connection" page, showing publications Mitchell Sokoloff has written about Risk Assessment.
Connection Strength
0.114
-
Sokoloff MH, Daneshmand S, Ryan CW. Current clinical trials in renal cell carcinoma. Urol Oncol. 2005 Jul-Aug; 23(4):289-92.
Score: 0.036
-
Jani AB, Sokoloff M, Shalhav A, Stadler W. Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis. Urology. 2004 Nov; 64(5):976-81.
Score: 0.034
-
Frendl DM, FitzGerald G, Epstein MM, Allison JJ, Sokoloff MH, Ware JE. Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: Development of a tool. PLoS One. 2020; 15(12):e0240039.
Score: 0.026
-
Chien GW, Orvieto MA, Galocy RM, Sokoloff MH, Shahav AL. Technical considerations for laparoscopic right renal surgery in presence of Riedel's lobe of the liver. J Endourol. 2005 Apr; 19(3):300-2.
Score: 0.009
-
Chien GW, Orvieto MA, Chuang MS, Sokoloff MH, Gerber GS, Shalhav AL. Use of suspension traction system for renal positioning during laparoscopic partial nephrectomy. J Endourol. 2005 Apr; 19(3):406-9.
Score: 0.009